Linkage analysis of putative schizophrenia gene candidate regions on chromosomes 3p, 5q, 6p, 8p, 20p and 22q in a population-based sampled Finnish family set

Molecular Psychiatry

Volumn 3, Issue 5, 1998, Pages 452-457

  Hovatta, I ^a,c   Lichtermann, D ^b   Juvonen, H ^a   Suvisaari, J ^a   Terwilliger, J D ^b   Arajarvi R ^b   Kokko Sahin, M L ^a   Ekelund, J ^a   Lonnqvist, J ^b   Peltonen, L ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Columbia University ^*  (United States)

Author keywords

Affected sib pair analysis; Genetic isolate; Psychiatry

Indexed keywords

ARTICLE; CHROMOSOME 20P; CHROMOSOME 22Q; CHROMOSOME 3P; CHROMOSOME 5Q; CHROMOSOME 6P; CHROMOSOME 8P; FINLAND; GENETIC LINKAGE; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0031718093     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000443     Document Type: Article

References (38)

1. Pulver AE, Lasseter VK, Kasch L, Wolyniec P, Nestadt G, Blouin J-L et al. Schizophrenia: a genome scan targets chromosomes 3p and 8p as potential sites of susceptibility genes. Am ] Mcd Genet 1995; CO: 252-260.
2. Schwab SG, Eckstein GN, Hallmayer J, Lerer B, Albus M, Borrmann M et al. Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis. Mol Psychiatry 1997; 2: 156-160.
3. Sträub RE, MacLean CJ, O'Neill FA, Walsh D, Kendler KS. Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families. Mol Psychiatry 1997; 2: 148-155.
4. Wang S, Sun C, Walczak CA, Ziegle JS, Kipps BR, Goldin LR et al. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet 1995; 10: 41-46.
5. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F et al. An international two-stage genome-wide search for schizophrenia susceptibility genes. Afa( Genet 1995; 11: 321-324.
6. Coon H, Holik J, Hoff M, Reimherr F, Wender P, Myles-Worsley M et al. Analysis of chromosome 22 markers in nine schizophrenia pedigrees. Am J Med Genet 1994; 54: 72-79.
7. Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, Nestadt G et al. Sequential strategy to identify a susceptibility gene for schizophrenia: report of potential linkage on chromosome 22ql2-ql3.1: Part 1. Am J Med Genet 1994; 54: 36-43.
8. Hovatta I, Terwilliger JD, Lichtermann D, Makikyro T, Suvisaari J, Peltonen L et ai. Schizophrenia in the genetic isolate of Finland. Am ] Med Genet 1997; 74: 353-360.
9. Kuokkanen S, Sundvall M, Terwilliger JD, Tienari PJ, Wikström J, Holmdahl R et a}. A putative vulnerability locus to multiple sclerosis maps to 5pl4-pl2 in a region syntenic to the murine locus Eae2. Nat Genet 1996; 13: 477-480.
10. Kuokkanen S, Gschwend M, Rioux JD, Daly MJ. Terwilliger JD, Tienari PJ et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997; 61: 1379-1387.
11. Pajukanta P, Nuotio I, Terwilliger JD, Porkka KVK, Ylitalo K, Pihlajamäki J et ai. Linkage of familial combined hyperlipidaemia to chromosome Iq21-q23. Nat Genet 1998; 18: 369-373.
12. A Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Am J Med Genet 1996; 67: 580-594.
13. Sträub RE, MacLcan CJ, O'Neill FA, Burke J, Murphy B, Duke F et al. A potential vulnerability locus for schizophrenia on chromosome Gp24-22: evidence for genetic heterogeneity. A'af Genet 1995; 11: 287-293.
14. Schwab SG, Albus M, Hallmayer J, Honig S, Borrmann M, Lichtermann D et al. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 1995; 11: 325-327.
15. Antonarakis SE, Blouin J-L, Pulver AE, Wolyniec P, Lasseter VK, Nestadt G et al. Schizophrenia susceptibility and chromosome 6p24-22 (letter). Nat Genet 1995; 11: 235-236.
16. Mowry BJ, Nancarrow DJ, Lennon DP, Sandkuijl LA, Crowe RR, Silverman JM et al. Schizophrenia susceptibility and chromosome 6p24-22 (letter). A'af Genet 1995; 11: 233-234.
17. Curling H, Kalsi G, Chen AH-S, Green M, Butler R, Read T et al. Schizophrenia susceptibility and chromosome 6p24-22 (letter). Araf Genet 1995; 11: 234-235.
18. Garner C, Kelly M, Cardon L, Joslyn G, Carey A, LeDuc C et al. Linkage analyses of schizophrenia to chromosome Gp24-p22: an attempt to replicate. Am J Med Genet 1996; 67: 595-610.
19. Brzustowicz LM, Honer WG, Chow EWC, Hogan J, Hodgkinson K, Bassett AS. Use of a quantitative trait to map a locus associated with severity of positive symptoms in familial schizophrenia to chromosome 6p. Am J Hum Genet 1997; 61: 1388-1396.
20. Kendler KS, MacLcan CJ, O'Neill FA, Burke J, Murphy B, Duke F et al. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish study of high-density schizophrenia families. Am J Psychiatry 1996; 153: 1534-1540.
21. Kunugi H, Curtis D, Vallada HP, Nanko S, Powell JF, Murray RM et al. A linkage study of schizophrenia with DNA markers from chromosome 8p21-p22 in 25 multiplex families. Schizophr Res 1996; 22: 61-68.
22. Coon H, Jensen S, Holik J, Hoff M, Myles-Worsley M, Reimherr F et al. Genomic scan for genes predisposing to schizophrenia. Am J Med Genet 1994; 54: 59-71.
23. Schwab SG, Lerer B, Albus M, Maier W, Hallmayer J, Fimmers R et al. Potential linkage for schizophrenia on chromosome 22ql2q!3: a replication study. Am J Med Genet 1995; GO: 436-443.
24. Polymeropoulos MH, Coon H, Byerley W, Gershon ES, Goldin L, Crow TJ et al. Search for a schizophrenia susceptibility locus on human chromosome 22. Am J Med Genet 1994; 54: 93-99.
25. Vallada H, Curtis D, Sham PC, Murray RM, McGuffin P, Nanko S et al. Chromosome 22 markers demonstrate transmission disequilibrium with schizophrenia. Psychiatr Genet 1995; 5: 127-130.
26. Moises HW, Yang L, Li T, Havsteen B, Fimmers R, Baur MP et al. Potential linkage disequilibrium between schizophrenia and locus D22S278 on the long arm of chromosome 22. Am J Med Genet 1995; 60: 465-467.
27. Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, Antonarakis S et al. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22ql2-ql3.1: Part 2. Am J Med Genet 1994; 54: 44-50.
28. Kalsi G, Brynjolfsson J, Butler R, Sherrington R, Curtis D, Sigmundsson T et al. Linkage analysis of chromosome 22ql2-13 in a United Kingdom/Icelandic sample of 23 multiplex schizophrenia families. Am J Med Genet 1995; GO: 298-301.
29. Riley B, Mogudi-Carter M, Jenkins T, Williamson R. No evidence for linkage of chromosome 22 markers to schizophrenia in southern African Bantu-speaking families. Am J Med Genet 199G; G7: 515522.
30. Terwilliger JD, Shannon WD, Lathrop GM, Nolan JP, Goldin LR, Chase GA et al. True and false positive peaks in genomewide scans: applications of length-biased sampling to linkage mapping. Am J Hum Genet 1997; 61: 430-438.
31. Blin N, Stafford DW. A general method for isolation of high molecular weight DMA from eukaryotes. Nucleic Acids [les 1976; 3: 2303-2308.
32. Syvänen A-C, Tilgmann C, Rinne J, Ulmanen I. Genetic polymorphism of catechol-0-methyltransferase (COMT): correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics 1997; 7: 65-71.
33. Pekkarinen P, Hovatta I, Hakola P, Järvi O, Kestilä M, Lenkkeri U et al. Assignment of the locus for PLO-SL, a frontal-lobe dementia with bone cysts, to 19ql3. Am J Hum Genet 1998; G2: 362-372.
34. Lathrop GM, Lalouel JM. Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet 1984; 36: 460-465.
35. Lathrop GM, Lalouel JM, Julier C, Ott J. Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sei USA 1984; 81: 3443-3446.
36. Lathrop GM, Lalouel JM, White RL. Construction of human linkage maps: likelihood calculations for multilocus linkage analysis. Genet Epidemiol 1986; 3: 39-52.
37. OU J. Linkage probability and its approximate confidence interval under possible heterogeneity. Genet Epidemiol Suppl 1986; l: 251-257.
38. I Hovatta, National Public Health Institute, Department of Human Molecular Genetics, Mannerheimintie 166, 00300 Helsinki, Finland. iiris.hovatta@ktl.fi 3 Present address: Department of Psychiatry, University of Bonn, Sigmund-Freud-Str 25, D-53105 Bonn, Germany. lichtermann@uni-bonn.de